跳至主要内容
临床试验/ITMCTR1900002579
ITMCTR1900002579招募中4 期

Clinical Study for Tongmai Yangxin Pill in Treating Premature Atrial Contraction With Qi and Yin Deficiency Syndrome

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1) In accordance with the above-mentioned diagnostic criteria for Chinese medicine, the syndrome of traditional Chinese medicine belongs to the syndrome of deficiency of Qi and Yin;
  • 2) In line with the above-mentioned Western diagnostic criteria, there are clinical symptoms, and the 24h dynamic electrocardiogram room is greater than or equal to 720 times earlier;
  • 3) Sign the informed consent form;
  • 4) Aged between 18 and 75 years, male or female.

排除标准

  • 1) There are clear predisposing factors, such as infection, electrolyte imbalance (hypokalemia, hypomagnesemia, hyperkalemia);
  • 2) Those who are allergic to the drug ingredients;
  • 3) Patients have other serious liver diseases, heart diseases, kidney diseases, and malignant tumors that affect the evaluation of this study;
  • 4) participated in other drug research within 3 months before using the study drug;
  • 5) Those who have been diagnosed as angina or chest pain caused by acute myocardial infarction, acute heart failure, severe neurosis, hyperthyroidism, gastroesophageal reflux disease and cervical spondylosis;
  • 6) pregnant or lactating women;
  • 7) Combined with severe hypertension (above blood pressure 180 / 110 mmHg), diabetic ketoacidosis, ketoacidosis and severe infection in the past 1 month;
  • 8) The investigator believes that he cannot participate in the clinical trial.

研究者

发起方
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

相似试验